Diabetic Retinopathy

"Diabetic Retinopathy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.

Descriptor ID	D003930
MeSH Number(s)	C11.768.257 C14.907.320.382 C19.246.099.500.382
Concept/Terms	Diabetic Retinopathy Diabetic Retinopathy Diabetic Retinopathies Retinopathies, Diabetic Retinopathy, Diabetic

Below are MeSH descriptors whose meaning is more general than "Diabetic Retinopathy".

Diseases [C]
Eye Diseases [C11]
Retinal Diseases [C11.768]
Diabetic Retinopathy [C11.768.257]
Cardiovascular Diseases [C14]
Vascular Diseases [C14.907]
Diabetic Angiopathies [C14.907.320]
Diabetic Retinopathy [C14.907.320.382]
Endocrine System Diseases [C19]
Diabetes Mellitus [C19.246]
Diabetes Complications [C19.246.099]
Diabetic Angiopathies [C19.246.099.500]
Diabetic Retinopathy [C19.246.099.500.382]

Below are MeSH descriptors whose meaning is more specific than "Diabetic Retinopathy".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Diabetic Retinopathy" by people in this website by year, and whether "Diabetic Retinopathy" was a major or minor topic of these publications.

Bar chart showing 90 publications over 21 distinct years, with a maximum of 9 publications in 2016 and 2018 and 2020 and 2021

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2002	1	0	1
2003	1	1	2
2004	1	1	2
2005	5	1	6
2006	4	0	4
2007	3	0	3
2008	0	1	1
2009	0	1	1
2010	6	0	6
2011	2	2	4
2012	1	0	1
2013	1	0	1
2014	3	0	3
2015	3	1	4
2016	8	1	9
2017	3	0	3
2018	8	1	9
2019	7	0	7
2020	9	0	9
2021	9	0	9
2022	5	0	5

Below are the most recent publications written about "Diabetic Retinopathy" by people in Profiles.

Wai KM, Saroj N, Boucher N, Aggarwal N, Ho AC, Rahimy E. Evaluating the Effect of Hypoglycemic Agents on Diabetic Retinopathy Progression. Ophthalmic Surg Lasers Imaging Retina. 2023 Mar; 54(3):158-165.

View in: PubMed
Wang R, McClard CK, Laswell S, Mahmoudzadeh R, Salabati M, Ammar M, Vannavong J, Aziz AA, Ewald A, Calvanese AV, Lehman EB, Fried S, Windham V, Strutt A, Saroj N, Khanani AM, Eichenbaum DA, Regillo C, Wykoff CC. Quantifying burden of intravitreal injections: questionnaire assessment of life impact of treatment by intravitreal injections (QUALITII). BMJ Open Ophthalmol. 2022 Dec; 7(1).

View in: PubMed
Salabati M, Mahmoudzadeh R, Starr MR, Zhang Q, Sharpe J, Hsu J, Ho AC, Regillo C, Kuriyan AE. REFRACTIVE ERROR CHANGE DURING TREATMENT OF DIABETIC MACULAR EDEMA: A Post Hoc Analysis of the Diabetic Retinopathy Clinical Research Protocol T Trial. Retina. 2022 11 01; 42(11):2059-2065.

View in: PubMed
Sarohia GS, Nanji K, Khan M, Khalid MF, Rosenberg D, Deonarain DM, Phillips MR, Thabane L, Kaiser PK, Garg SJ, Sivaprasad S, Wykoff CC, Chaudhary V. Treat-and-extend versus alternate dosing strategies with anti-vascular endothelial growth factor agents to treat center involving diabetic macular edema: A systematic review and meta-analysis of 2,346 eyes. Surv Ophthalmol. 2022 Sep-Oct; 67(5):1346-1363.

View in: PubMed
Yan Z, Wang C, Meng Z, Gan L, Guo R, Liu J, Bond Lau W, Xie D, Zhao J, Lopez BL, Christopher TA, Naik UP, Ma X, Wang Y. C1q/TNF-Related Protein 3 Prevents Diabetic Retinopathy via AMPK-Dependent Stabilization of Blood-Retinal Barrier Tight Junctions. Cells. 2022 02 23; 11(5).

View in: PubMed
Bowe T, Salabati M, Soares RR, Huang C, Singh RP, Khan MA, Williams BK, Sridhar J, Chiang A, Cohen MN, Klufas MA, Gupta OP, Yonekawa Y, Xu D, Kuriyan AE. Racial, Ethnic, and Gender Disparities in Diabetic Macular Edema Clinical Trials. Ophthalmol Retina. 2022 06; 6(6):531-533.

View in: PubMed
Behera UC, Salzman B, Das AV, Prashanthi GS, Lalakia P, Derman R, Panigrahy B. Prevalence of chronic disease in older adults in multitier eye-care facilities in South India: Electronic medical records-driven big data analytics report. Indian J Ophthalmol. 2021 Dec; 69(12):3618-3622.

View in: PubMed
Dugel PU, Khanani AM, Berger BB, Patel S, Fineman M, Jaffe GJ, Kozma-Wiebe P, Heier J. Phase 1 Dose-Escalation Study of Plasma Kallikrein Inhibitor THR-149 for the Treatment of Diabetic Macular Edema. Transl Vis Sci Technol. 2021 12 01; 10(14):28.

View in: PubMed
Nanji K, Khan M, Khalid MF, Xie JS, Sarohia GS, Phillips M, Thabane L, Garg SJ, Kaiser P, Sivaprasad S, Wykoff CC, Chaudhary V. Treat-and-extend regimens of anti-vascular endothelial growth factor therapy for retinal vein occlusions: a systematic review and meta-analysis. Acta Ophthalmol. 2022 Sep; 100(6):e1199-e1208.

View in: PubMed
Ipp E, Liljenquist D, Bode B, Shah VN, Silverstein S, Regillo CD, Lim JI, Sadda S, Domalpally A, Gray G, Bhaskaranand M, Ramachandra C, Solanki K. Pivotal Evaluation of an Artificial Intelligence System for Autonomous Detection of Referrable and Vision-Threatening Diabetic Retinopathy. JAMA Netw Open. 2021 11 01; 4(11):e2134254.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement